Benzoyl peroxide acts in acne vulgaris by:
Acid that is decreased in acne comedones is?
Topical antiviral drugs are not indicated in:
A child presents with grouped vesicles on the lips. What is the bedside investigation that you would like to do?
A cosmetic dermatologist plans to introduce microneedling radiofrequency for acne scars. Which parameter combination would provide optimal collagen remodeling with minimal risk of thermal injury in Fitzpatrick type IV skin?
A 50-year-old man with Fitzpatrick skin type V desires treatment for melasma. He was previously treated with triple combination cream with partial response. What would be the most evidence-based next step considering safety and efficacy?
A patient treated with Q-switched Nd:YAG laser for nevus of Ota develops paradoxical darkening after 4 weeks. What is the most likely explanation for this phenomenon?
A 42-year-old woman develops sudden onset vision loss in one eye 2 hours after hyaluronic acid filler injection in the glabella. Fundoscopy shows retinal whitening. What is the underlying pathophysiology?
A 28-year-old patient undergoes 70% glycolic acid peel for acne scars. Two hours post-procedure, he develops severe burning and erythema. What is the most appropriate immediate management?
A 35-year-old woman desires correction of nasolabial folds. She has a history of herpes simplex labialis. Which dermal filler should be avoided?
Explanation: ***Decreasing bacterial count*** - **Benzoyl peroxide** is a highly effective topical treatment for acne primarily due to its potent **antimicrobial activity** against *Cutibacterium acnes*, the bacterium implicated in acne pathogenesis. - It works by releasing **free radicals** that disrupt bacterial cell membranes and metabolism, thereby reducing the bacterial load in follicles. *Reduces sebum production* - While sebaceous gland activity is critical in acne, benzoyl peroxide does **not directly reduce sebum production**; retinoids like isotretinoin are known for this effect. - Its primary action is focused on combating bacteria and mildly promoting desquamation rather than affecting **lipid synthesis**. *Acts as a keratolytic agent* - Benzoyl peroxide does possess some **keratolytic activity**, aiding in the shedding of dead skin cells and preventing pore blockage. - However, its keratolytic action is **less pronounced** compared to agents like salicylic acid or tretinoin, and it is not its primary mechanism of action. *Increases epithelial turnover* - While benzoyl peroxide does promote a mild increase in **epithelial cell turnover**, helping to clear clogged pores, it is not its main mechanism of action or defining characteristic. - **Topical retinoids** (e.g., tretinoin, adapalene) are far more effective and primarily used to normalize follicular keratinization and increase cell turnover.
Explanation: ***Linoleic acid*** - A decrease in **linoleic acid** (an essential fatty acid) within the sebum leads to increased **comedone formation** in acne. - Reduced linoleic acid alters the **sebum composition**, making it more pro-inflammatory and less fluid, which contributes to follicular plugging. *Palmitic acid* - **Palmitic acid** is a common **saturated fatty acid** found in sebum, and its levels are generally not decreased in acne comedones; rather, the *ratio* of fatty acids is altered. - It is a major component of **triglycerides** and is often found in *higher proportions* relative to essential fatty acids in acne-prone skin. *Acetic acid* - **Acetic acid** is a **short-chain fatty acid** and is not a primary component of human sebum in significant quantities, nor is its decrease implicated in acne pathogenesis. - It is more commonly associated with microbial metabolism or certain skin infections rather than sebaceous gland dysfunction in acne. *Linolenic acid* - **Linolenic acid** (alpha-linolenic acid) is another **essential fatty acid**, but it is **linoleic acid** (omega-6) that is specifically found to be decreased in acne comedones and is more directly implicated in the pathology. - While important for skin health, its role in acne is generally less prominent than that of linoleic acid.
Explanation: ***Metaherpetic ulcer*** - Metaherpetic ulcers are **neurotrophic ulcers** that develop as a result of chronic epithelial damage and impaired healing after a herpes simplex virus (HSV) infection, but they are not an active viral replication process. - Topical antivirals are ineffective because there is **no replicating virus** to target; management focuses on promoting corneal healing and preventing secondary infections. *Dendritic ulcer* - A dendritic ulcer is a classic sign of **active HSV keratitis** with replicating virus in the epithelial cells. - Topical antiviral drugs (e.g., acyclovir, ganciclovir) are the **first-line treatment** to inhibit viral replication and promote epithelial healing. *Stromal necrotizing keratitis* - This condition involves **inflammation and necrosis** in the corneal stroma, often due to an immune reaction to HSV antigens rather than direct viral invasion. - While topical antivirals may be used to suppress any residual replicating virus, **topical corticosteroids are often necessary** to control the inflammation, and close monitoring is crucial due to the risk of steroid-induced complications. *All of the options* - This option is incorrect because topical antiviral drugs *are* indicated for **dendritic ulcers** and sometimes as adjunctive therapy for **stromal necrotizing keratitis** where active viral replication might be contributing.
Explanation: ***Tzanck smear*** - A **Tzanck smear** is a rapid bedside test that can identify **multinucleated giant cells**, which are seen in herpes simplex virus infections. - The presence of **grouped vesicles on the lips** is highly suggestive of **herpes labialis** (HSV-1), which is primarily a **clinical diagnosis**. - Among the options provided, Tzanck smear is the only relevant bedside investigation, though it has **limited sensitivity and specificity** and **cannot distinguish between HSV and VZV**. - In modern practice, **PCR or direct immunofluorescence** are preferred when laboratory confirmation is needed, but Tzanck smear remains a low-cost option in resource-limited settings. *Wood's lamp* - A Wood's lamp uses **ultraviolet light** to detect certain fungal or bacterial infections by revealing characteristic fluorescence. - It is useful for conditions like **tinea capitis** (green fluorescence) and **erythrasma** (coral-red fluorescence), but has no role in diagnosing viral vesicular lesions. *Slit skin smear* - A **slit skin smear** is used to detect **acid-fast bacilli** in the diagnosis of **leprosy**. - It is not indicated for vesicular lesions and is irrelevant to herpes simplex infection. *KOH* - A **KOH (potassium hydroxide) mount** is used to diagnose **fungal infections** by dissolving keratinocytes and revealing fungal hyphae or spores. - It has no utility in diagnosing viral infections such as herpes simplex.
Explanation: ***Needle depth 1.5-2 mm, temperature 60-65°C, pulse duration 100-200 ms*** - Optimal **collagen remodeling** occurs when the tissue is heated to **60-65°C**, which triggers the denaturation of proteins and the subsequent production of new collagen and elastin. - A depth of **1.5-2 mm** specifically targets the **papillary and mid-reticular dermis**, while the shorter pulse duration minimizes **Post-Inflammatory Hyperpigmentation (PIH)** in **Fitzpatrick type IV** skin. *Needle depth 3.5 mm, temperature 70°C, pulse duration 1000 ms* - Temperatures reaching **70°C** and very high pulse durations significantly increase the risk of **thermal necrosis** and bulk heating injuries. - A depth of **3.5 mm** is often too deep for standard facial acne scarring and may damage underlying **subcutaneous structures** or cause permanent scarring. *Needle depth 4 mm, temperature 75°C, pulse duration 500 ms* - High temperatures of **75°C** cause excessive tissue coagulation, which can lead to localized **skin burns** and prolonged downtime. - Excessive needle depth combined with high energy delivery poses a severe risk for **atrophic scarring** and pigmentary changes in darker skin types. *Needle depth 0.5 mm, temperature 55°C, pulse duration 50 ms* - A depth of **0.5 mm** is generally insufficient to reach the collagen-rich dermis required for significant improvement of **depressed acne scars**. - A temperature of **55°C** is below the threshold for effective **collagen denaturation**, resulting in suboptimal clinical outcomes for scar revision.
Explanation: ***Q-switched Nd:YAG laser 1064 nm with low fluence*** - This approach, often called **laser toning**, uses a long wavelength that spares the epidermis, making it the safest laser option for **Fitzpatrick skin type V** to avoid **post-inflammatory hyperpigmentation (PIH)**. - It is a clinically sound next step for **recalcitrant melasma** that has only partially responded to first-line therapies like **triple combination cream**. *Fractional CO2 laser resurfacing* - This is an **ablative** treatment that causes significant thermal damage, which carries an unacceptably high risk of **PIH** and scarring in darker skin types. - While effective for skin remodeling, it is generally contraindicated for treating melasma in **type V skin** due to the likelihood of worsening the pigmentation. *Intense pulsed light therapy* - **IPL** uses a broad spectrum of light which is poorly targeted for melasma in dark-skinned individuals and is frequently associated with **rebound hyperpigmentation**. - The melanin in the surrounding **darker skin (Type V)** competes for the energy, leading to a high risk of **thermal burns** and uneven results. *TCA 35% chemical peel* - A 35% concentration of **Trichloroacetic acid (TCA)** is considered a **medium-depth peel**, which is generally too aggressive for patients with Fitzpatrick skin type V. - Medium-depth peels in dark skin types are likely to cause **persistent dyschromia** or permanent **hypopigmentation**, whereas superficial peels (like glycolic or salicylic acid) are safer.
Explanation: ***Increased melanogenesis due to suboptimal fluence*** - Paradoxical darkening in **nevus of Ota** during **Q-switched Nd:YAG** therapy often results from **suboptimal fluence**, which triggers reactive **melanogenesis** instead of destroying the target cells. - This occurs when the energy delivered is sufficient to stimulate **dermal melanocytes** but remains below the threshold required for **selective photothermolysis** and cell destruction. *Delayed clearance in deeper dermal melanocytes* - Delayed clearance typically results in a slow resolution of the lesion rather than an actual **increase in pigmentation** or darkening. - The darkening suggests an active production of **melanin** rather than a passive failure of the lymphatic system to clear debris. *Post-inflammatory hyperpigmentation due to epidermal injury* - **Post-inflammatory hyperpigmentation (PIH)** usually presents as a more generalized or superficial brownish tan following **epidermal damage**. - While common in darker skin types, the term "paradoxical darkening" in the context of dermal lesions specifically refers to the reactive stimulation of **dermal melanocytes**. *Conversion to melanoma* - There is no clinical or histopathological evidence that **Q-switched lasers** induce **malignant transformation** or conversion of a benign nevus to **melanoma**. - While **nevus of Ota** has a small baseline risk of ocular or CNS melanoma, laser-induced darkening is a transient physiological response, not a neoplastic change.
Explanation: ***Retrograde embolization via angular artery to ophthalmic artery*** - Glabellar filler injection can inadvertently enter the **angular artery**, where high injection pressure forces the filler **retrograde** into the **ophthalmic artery**. - Once pressure is released, the filler travels antegrade into the **central retinal artery**, causing occlusion and classic **retinal whitening** due to ischemia. *Compression of supraorbital nerve* - This would lead to **sensory changes** or pain in the forehead region rather than sudden, painless vision loss. - Nerve compression does not explain the **fundoscopic finding** of retinal whitening or vascular compromise. *Direct traumatic optic nerve injury* - The **optic nerve** is located deep within the orbit and is not typically reachable by standard aesthetic needles used in the glabella. - Traumatic injury would likely present with an **afferent pupillary defect** without the characteristic **ischemic retinal whitening** associated with artery occlusion. *Allergic reaction causing optic neuritis* - **Optic neuritis** presents with painful eye movements and inflammatory changes, rather than the hyper-acute vision loss seen in arterial embolization. - A localized allergic reaction to **hyaluronic acid** would cause significant swelling and redness at the injection site rather than sudden **retinal ischemia**.
Explanation: ***Apply cold compresses and emollient*** - Severe burning and erythema two hours post-procedure are managed with **cold compresses** to soothe inflammation and **bland emollients** to restore the skin barrier. - At this stage, the chemical agent has already been processed; management focuses on **symptomatic relief** and preventing post-inflammatory hyperpigmentation. *Apply topical steroid immediately* - Topical steroids are generally avoided immediately after a chemical peel as they may **interfere with the natural healing process** and re-epithelialization. - They are typically reserved for persistent, **prolonged erythema** that does not subside with standard post-peel care. *Start oral corticosteroids* - Systemic steroids are disproportionate for post-peel erythema and are rarely indicated unless there is a severe **systemic allergic reaction**. - Routine management of peel complications involves **local topical therapies** rather than systemic immunosuppression. *Neutralize with sodium bicarbonate solution* - Neutralization with **sodium bicarbonate** must be performed **intra-procedure** once the desired clinical endpoint (like frosting or erythema) is reached. - Two hours post-procedure is **too late** for neutralization as the acid has already been neutralized or absorbed, making this intervention ineffective.
Explanation: ***Polymethylmethacrylate*** - **Polymethylmethacrylate (PMMA)** is a **permanent dermal filler** that carries a higher risk of **granuloma formation**, particularly in patients with recurrent viral infections like **herpes simplex labialis**. - Injecting permanent fillers into areas of high mobility like the **nasolabial folds** in patients with active or recurrent infections can lead to chronic **inflammatory complications** and reactivation of the virus. *Calcium hydroxylapatite* - This is a **semi-permanent filler** often used for deep facial folds but is not specifically contraindicated based solely on a **herpes history**, provided prophylactic antivirals are used. - It acts as a **biostimulator** and is generally safe, though it cannot be easily reversed if a complication occurs compared to hyaluronic acid. *Hyaluronic acid* - **Hyaluronic acid (HA)** is the preferred choice for this patient because it is **reversible** using the enzyme **hyaluronidase** if a flare-up or complication occurs. - While any filler can trigger a **herpes flare**, HA has a lower profile for high-grade inflammatory reactions and is considered the **gold standard** for nasolabial folds. *Poly-L-lactic acid* - This is a **biodegradable, synthetic polymer** that stimulates collagen production over time rather than providing immediate volume. - It is generally used for global facial volumization rather than targeted **nasolabial fold** correction and does not carry the specific permanent risk profile of **PMMA**.
Get full access to all questions, explanations, and performance tracking.
Start For Free